5-methyldeoxycytidine

Also Known As:

5-methyl-2'-deoxycytidine

Networked: 19 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Deoxycytidine: 307
        5-methyldeoxycytidine: 19
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Deoxycytidine: 307
        5-methyldeoxycytidine: 19
  - Deoxyribonucleosides: 34
    - Deoxycytidine: 307
      - 5-methyldeoxycytidine: 19

Experts

1.	Wang, Yinsheng: 2 articles (11/2018 - 12/2011)
2.	Foster, Barbara A: 2 articles (08/2008 - 12/2006)
3.	James, Smitha R: 2 articles (08/2008 - 12/2006)
4.	Karpf, Adam R: 2 articles (08/2008 - 12/2006)
5.	Moser, Michael T: 2 articles (08/2008 - 12/2006)
6.	Smiraglia, Dominic J: 2 articles (08/2008 - 12/2006)
7.	García-Calderón, Clara B: 1 article (05/2022)
8.	Klimašauskas, Saulius: 1 article (05/2022)
9.	Moreno-Gordillo, Paula: 1 article (05/2022)
10.	Narmontė, Milda: 1 article (05/2022)

Related Diseases

1.	Chronic Hepatitis B 03/01/2023 - "This study attempts to investigate the serum levels of circulating cf-DNA and 5-methyl-2'-deoxycytidine in HBeAg-negative patients with chronic infection (carriers) and chronic hepatitis B (CHB), as well as their changes after treatment initiation in CHB. "
2.	Liver Diseases (Liver Disease) 03/01/2023 - "Both circulating levels of cf-DNA and 5-methyl-2'-deoxycytidine might be useful biomarkers in order to monitor liver disease activity and response to antiviral treatment in HBeAg-negative chronic HBV patients, but further studies are essential in order to validate these intriguing findings."
3.	Carcinoma (Carcinomatosis) 01/01/2019 - "The aim of this study is the first to explore the effect of interactions of urinary total arsenic levels, arsenic methylation capacity, 8-hydroxy-2'-deoxyguanosine (8-OHdG), plasma folate, and global 5-methyl-2'-deoxycytidine (5-MedC) levels on the risk of urothelial carcinoma (UC). "
4.	Persistent Infection 03/01/2023 - "This study attempts to investigate the serum levels of circulating cf-DNA and 5-methyl-2'-deoxycytidine in HBeAg-negative patients with chronic infection (carriers) and chronic hepatitis B (CHB), as well as their changes after treatment initiation in CHB. "
5.	Neoplasms (Cancer) 04/09/2021 - "We quantified ADK-L expression (Western Blot) and global DNA methylation as percent 5-methyldeoxycytidine (5mdC, LC-MS/MS) in three cancer lines (HeLa, HepG2, and U373). " 01/01/2017 - "Similar analyses of a broader spectrum of epigenetic modifications, not restricted to 5-methyl-2'-deoxycytidine, could lead to better understanding of the mechanism(s) responsible for emergence of different types of cancer cells." 12/15/2006 - "We analyzed DNA methylation in TRAMP and found that global levels of 5-methyl-2'-deoxycytidine are unaltered, whereas specific tumors display centromeric repeat hypomethylation. " 01/31/1995 - "Then the inhibition ELISA system using AMC was established and urinary levels of 5-methyl-2'-deoxycytidine in healthy individuals and cancer patients were determined. " 01/31/1995 - "Among various types of cancer tested, elevated levels of 5-methyl-2'-deoxycytidine were detected in leukemia patients. "

Related Drugs and Biologics

1.	DNA (Deoxyribonucleic Acid)
2.	Biomarkers (Surrogate Marker)
3.	Hepatitis B e Antigens
4.	Folic Acid (Vitamin M)
5.	Arsenic
6.	Antiviral Agents (Antivirals)
7.	8-Hydroxy-2'-Deoxyguanosine
8.	5-hydroxymethyl-2'-deoxycytidine
9.	A-Form DNA (A-DNA)
10.	Tetrahydrouridine

Related Therapies and Procedures

1.	Aftercare (After-Treatment)